Philip Marsden is a panelist during the session titled “Excessive prices in pharmaceutical markets.”
For more information on this event, click here.
CRA engagements win in 2024 GCR Awards
The high-profile acquisition of Activision by Microsoft, which CRA Competition’s teams advised on was named overall Matter of the Year, as well as Matter of...